Document is current
Any future updates will be listed below
-
Authors
Mangaonkar, Abhishek A. https://orcid.org/0000-0003-2458-9887
Lasho, Terra L.
Ketterling, Rhett P.
Reichard, Kaaren K.
Gangat, Naseema https://orcid.org/0000-0002-9104-6172
Al-Kali, Aref https://orcid.org/0000-0002-0824-3715
Begna, Kebede H.
Pardanani, Animesh
Al Ali, Najla H.
Talati, Chetasi https://orcid.org/0000-0002-2246-213X
Sallman, David https://orcid.org/0000-0003-0504-8233
Padron, Eric https://orcid.org/0000-0002-4707-7916
Patnaik, Mrinal M. https://orcid.org/0000-0001-6998-662X
Tefferi, Ayalew https://orcid.org/0000-0003-4605-3821
Komrokji, Rami https://orcid.org/0000-0002-1876-5269
- License Information
-
More Information
Article History
Received: 17 October 2021
Revised: 16 January 2022
Accepted: 20 January 2022
First Online: 1 February 2022
Competing interests
: EP has received honoraria and/or serves on advisory boards of BluePrint, CTI, Stemline Therapeutics, Taiho, and BMS; and has received research funding from Kura, Incyte, and BMS. MP is on the advisory board of Stemline Therapeutics. All other authors declare no relevant conflicts of interest in relation to the manuscript.
